US20240025908, Example 2
3-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-5-N-[(1R)-1-(2,3,5-trifluorophenyl)ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine
Molecular Identity
US20240025908, Example 2
3-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-5-N-[(1R)-1-(2,3,5-trifluorophenyl)ethyl]pyrazolo[1,5-a]pyrimidine-3,5-diamine
PubChem CID: 170680074
2D Structure
Properties
C19H19F3N6O
Molecular Formula
404.40
Molecular Weight
g/mol
404.1572
Exact Mass
Da
2.7
XLogP
Drug-like (Lipinski: < 5)
75.8
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
8
H-Bond Acceptors
623
Complexity
SMILES
Canonical SMILES
SMILES: CC(C1=C(C(=CC(=C1)F)F)F)NC2=NC3=C(C=NN3C=C2)NC4=NC(CO4)(C)CIsomeric SMILES
SMILES: C[C@H](C1=C(C(=CC(=C1)F)F)F)NC2=NC3=C(C=NN3C=C2)NC4=NC(CO4)(C)CSynonyms(4)
SCHEMBL27060125BDBM647634US20240025908, Example 2T-02
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to US20240025908, Example 2
Loading drug network...